Karyopharm Therapeut (KPTI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Sales | 35,100 | 21,333 | 33,514 | 18,138 | 18,096 |
| Cost of Goods | 1,052 | 438 | 396 | 819 | 1,394 |
| Gross Profit | 34,048 | 20,895 | 33,118 | 17,319 | 16,702 |
| Operating Expenses | 71,166 | 68,442 | 73,833 | 65,494 | 60,362 |
| Operating Income | -37,066 | -47,109 | -40,319 | -47,356 | -43,266 |
| Interest Expense | 7,072 | 6,801 | 6,758 | 6,509 | 6,467 |
| Other Income | 779 | 459 | 788 | 1,000 | 1,088 |
| Pre-tax Income | -43,359 | -53,451 | -46,289 | -52,865 | -48,645 |
| Income Tax | 62 | 44 | 137 | 66 | 2 |
| Net Income Continuous | -43,421 | -53,495 | -46,426 | -52,931 | -48,647 |
| Net Income | $-43,421 | $-53,495 | $-46,426 | $-52,931 | $-48,647 |
| EPS Basic Total Ops | -8.70 | -10.94 | -9.45 | -11.69 | -11.24 |
| EPS Basic Continuous Ops | -8.69 | -10.92 | -9.50 | -11.73 | -11.33 |
| EPS Diluted Total Ops | -8.70 | -10.94 | -9.45 | -11.69 | -11.24 |
| EPS Diluted Continuous Ops | -8.69 | -10.92 | -9.50 | -11.73 | -11.33 |
| EBITDA(a) | $-33,974 | $-44,227 | $-37,997 | $-45,190 | $-41,267 |